SymBio Pharmaceuticals
SymBio Pharmaceuticals aims to develop drugs for patients overlooked by the industry, ensuring vital treatments reach those in need.
Launch date
Employees
Market cap
AUD131m
Enterprise valuation
AUD56m (Public information from Sep 2024)
Share price
JPY252 4582.T
Tokyo Japan (HQ)
Authorizing premium user...